Amneal Pharmaceuticals Price Performance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amneal pharmaceuticals price performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amneal Pharmaceuticals Price Performance Today - Breaking & Trending Today

Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 1.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) shot up 1.9% on Wednesday . The company traded as high as $5.86 and last traded at $5.84. 420,424 shares were traded during trading, a decline of 72% from the average session volume of 1,499,807 shares. The stock had previously closed at $5.73. Analyst Ratings Changes A […] ....

Piper Sandler , Voloridge Investment Management , News Ratings For Amneal Pharmaceuticals Daily , Barclays Plc , Group Plc , Institutional Investors Weigh In On Amneal Pharmaceuticals , Goldman Sachs Group , Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Amneal Pharmaceuticals Price Performance , Vanguard Group Inc , Get Free Report , General Group Plc , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals (NASDAQ:AMRX) Sees Strong Trading Volume

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) saw unusually-strong trading volume on Wednesday . Approximately 454,208 shares traded hands during mid-day trading, a decline of 69% from the previous session’s volume of 1,481,910 shares.The stock last traded at $5.96 and had previously closed at $5.81. Wall Street Analyst Weigh In Several research analysts recently […] ....

Hong Kong , United States , Piper Sandler , American Century Companies Inc , Y Intercept Hong Kong Ltd , Amneal Pharmaceuticals Price Performance , Tower Research Capital , Amneal Pharmaceuticals Inc , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Company Profile , Pricet Rowe Associates Inc , Amneal Pharmaceuticals , Goldman Sachs Group , Institutional Investors Weigh In On Amneal Pharmaceuticals , Get Free Report , Century Companies , Gate Manager , Research Capital , Amneal Pharmaceuticals Daily ,

Connor Clark & Lunn Investment Management Ltd. Boosts Stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

Connor Clark & Lunn Investment Management Ltd. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 492,304 shares of the company’s stock after buying an additional 107,090 shares […] ....

Blackrock Inc , Connor Clark Lunn Investment Management Ltd , Amneal Pharmaceuticals , Metlife Investment Management , Panagora Asset Management Inc , Exchange Commission , Quarter For Amneal Pharmaceuticals , News Ratings For Amneal Pharmaceuticals Daily , York Mellon Corp , Amneal Pharmaceuticals Inc , Amneal Pharmaceuticals Profile , Amneal Pharmaceuticals Price Performance , Swiss National Bank , Connor Clark , Lunn Investment Management , Free Report , National Bank , New York Mellon Corp , Life Investment Management , Asset Management , Visit Holdingschannel , Amneal Pharmaceuticals Daily , Nasdaq Amrx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $4.80 Consensus Target Price from Analysts

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have received a consensus rating of “Moderate Buy” from the five ratings firms that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 […] ....

United States , Hong Kong , Amneal Pharmaceuticals Company Profile , Institutional Investors Weigh In On Amneal Pharmaceuticals , Analyst Recommendations For Amneal Pharmaceuticals , Pricet Rowe Associates Inc , Amneal Pharmaceuticals Inc , Tower Research Capital , Amneal Pharmaceuticals , American Century Companies Inc , Y Intercept Hong Kong Ltd , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Price Performance , Get Free Report , Marketbeat Ratings , Century Companies , Gate Manager , Research Capital , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Receives $4.80 Average Target Price from Analysts

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price […] ....

Analyst Recommendations For Amneal Pharmaceuticals , Panagora Asset Management Inc , Amneal Pharmaceuticals , Metlife Investment Management , News Ratings For Amneal Pharmaceuticals Daily , Amneal Pharmaceuticals Price Performance , Hedge Funds Weigh In On Amneal Pharmaceuticals , Amneal Pharmaceuticals Inc , York Mellon Corp , Swiss National Bank , Amneal Pharmaceuticals Company Profile , Blackrock Inc , Get Free Report , Marketbeat Ratings , National Bank , New York Mellon Corp , Life Investment Management , Asset Management , Get Free , Amneal Pharmaceuticals Daily , Nasdaq Amrx ,